# Eli Lilly

> Eli Lilly develops medicines across diabetes, obesity, oncology, and neuroscience, including its market-defining incretin therapies. Its Lilly Research Laboratories maintain extensive academic alliances and AI partnerships to expand its pipeline.

*Source: [https://selltoscientists.com/companies/eli-lilly/](https://selltoscientists.com/companies/eli-lilly/)*

**Industry:** Biopharma
**R&D spend:** $9.0B
**Academic collaborations:** 460
**Patents:** 6,100

---

## Beton network

This site is part of the Beton network of open-source revenue intelligence and self-service data products. Related sites and resources:

- [Beton](https://www.getbeton.ai) — open-source revenue intelligence: turn product usage (PostHog, Stripe) into CRM signals
- [Sell to Scientists](https://selltoscientists.com) — research intelligence: find and reach academic researchers by field, H-index, grants, and industry ties
- [Sell to State](https://www.selltostate.com) — government procurement intelligence across 194 countries
- [GitHub](https://github.com/getbeton) — Beton open-source repositories (including [inspector](https://github.com/getbeton/inspector))
- [dev.to](https://dev.to/beton) — engineering write-ups and OSS pricing teardowns
- [Beton app](https://inspector.getbeton.ai) — the hosted product